Literature DB >> 10193389

Early childhood infection and atopic disorder.

I S Farooqi1, J M Hopkin.   

Abstract

BACKGROUND: Atopy is of complex origins but the recent rise in atopic diseases in westernized communities points to the action of important environmental effects. One candidate mechanism is the changing pattern of microbial exposure in childhood. This epidemiological study investigated the relationship between childhood infections and subsequent atopic disease, taking into account a range of social and medical variables.
METHODS: A total of 1934 subjects representing a retrospective 1975-84 birth group at a family doctor practice in Oxfordshire were studied. Public health and practice records were reviewed; temporal records were made of all diagnoses of infections and their treatments, all immunisations, and diagnoses of asthma, hay fever and eczema; maternal atopy and a number of other variables were documented.
RESULTS: Logistic regression analysis identified three statistically significant predictors of subsequent atopic disease: maternal atopy (1.97, 95% CI 1.46 to 2.66, p < 0.0001), immunisation with whole-cell pertussis vaccine (1.76, 95% CI 1.39 to 2.23, p < 0.0001), and treatment with oral antibiotics in the first two years of life (2.07, 95% CI 1.64 to 2.60, p < 0.0001). There was no significant association found for maternal smoking, bottle feeding, sibship size, or social class.
CONCLUSIONS: The prediction of atopic disease by maternal atopy mainly reflects the effect of acknowledged genetic factors. Interpretation of the prediction of atopic disorders by immunisation with wholecell pertussis vaccine and treatment with oral antibiotics needs to be very cautious because of the possibilities of confounding effects and reverse causation. However, plausible immune mechanisms are identifiable for the promotion of atopic disorders by both factors and further investigation of these association is warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10193389      PMCID: PMC1745117          DOI: 10.1136/thx.53.11.927

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

1.  Hay fever, hygiene, and household size.

Authors:  D P Strachan
Journal:  BMJ       Date:  1989-11-18

2.  The mechanism of the adjuvant effect of Bordetella pertussis: the substance responsible for the selective enhancement of IgE antibody production.

Authors:  I Mota; A Perini; V S Trindade
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

3.  Changes in asthma prevalence: two surveys 15 years apart.

Authors:  M L Burr; B K Butland; S King; E Vaughan-Williams
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

4.  The non-specific enhancement of allergy. I. In vivo effects of Bordetella pertussis vaccine on IgE synthesis.

Authors:  R Pauwels; M Van der Straeten; B Platteau; H Bazin
Journal:  Allergy       Date:  1983-05       Impact factor: 13.146

5.  Action of pertussigen (pertussis toxin) on serum IgE and on Fc epsilon receptors on lymphocytes.

Authors:  J J Munoz; M G Peacock
Journal:  Cell Immunol       Date:  1990-05       Impact factor: 4.868

6.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates.

Authors:  F D Martinez; A L Wright; L M Taussig; C J Holberg; M Halonen; W J Morgan
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

7.  Croup, recurrent group, allergy, and airways hyper-reactivity.

Authors:  M Zach; A Erben; A Olinsky
Journal:  Arch Dis Child       Date:  1981-05       Impact factor: 3.791

8.  A role for intestinal T lymphocytes in bronchus mucosal immunity.

Authors:  F J Wallace; A W Cripps; R L Clancy; A J Husband; C S Witt
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

9.  The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years.

Authors:  R C Welliver; L Duffy
Journal:  Pediatr Pulmonol       Date:  1993-01

10.  Cord serum IgE in relation to family history and as predictor of atopic disease in early infancy.

Authors:  C G Magnusson
Journal:  Allergy       Date:  1988-05       Impact factor: 13.146

View more
  57 in total

1.  Infections prevent the development of asthma--true, false or both?

Authors:  P J Openshaw; G Walzl
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

2.  Introduction

Authors: 
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 3.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

4.  Age at childhood infections and risk of atopy.

Authors:  P Bager; T Westergaard; K Rostgaard; H Hjalgrim; M Melbye
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 5.  The bifidobacterial and Lactobacillus microflora of humans.

Authors:  Gerald W Tannock
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

6.  Pertussis vaccination and wheezing illnesses in young children: prospective cohort study. The Longitudinal Study of Pregnancy and Childhood Team.

Authors:  J Henderson; K North; M Griffiths; I Harvey; J Golding
Journal:  BMJ       Date:  1999-05-01

7.  Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.

Authors:  E J Ryan; L Nilsson; N Kjellman; L Gothefors; K H Mills
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

8.  The early life origins of asthma and related allergic disorders.

Authors:  J O Warner
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

Review 9.  Pro and anti: the biotics of allergic disease.

Authors:  J Crane
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

10.  Childhood infections and risk of wheezing and allergic sensitisation at age 7-8 years.

Authors:  Monique Mommers; Gerard M H Swaen; Michaela Weishoff-Houben; Huub Creemers; Hermann Freund; Wolfgang Dott; Constant P van Schayck
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.